Theodore J. Theophilos
President chez Lurie Holdings, Inc.
Profil
Theodore J.
Theophilos is currently a Director at Viamet Pharmaceuticals, Inc. and Innocrin Pharmaceuticals, Inc. He will also be a Director at Robocast, Inc. and President & Secretary at Lurie Holdings, Inc. starting in 2022 and 2023 respectively.
Previously, he was a Group President-Corporate Strategic Initiatives at R.R.
Donnelley & Sons Co. and an Executive Vice President-Legal Affairs at Moore Wallace, Inc. He received his undergraduate and graduate degrees from Northwestern University and his graduate degree from The University of Chicago.
He also received his undergraduate degree from The University of Chicago Law School in 1979.
Postes actifs de Theodore J. Theophilos
| Sociétés | Poste | Début |
|---|---|---|
Innocrin Pharmaceuticals, Inc.
 Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC. | Directeur/Membre du Conseil | - |
Robocast , Inc.
 Robocast , Inc. Internet Software/ServicesTechnology Services Robocast, Inc. is a company that licenses its methods and technologies to major companies. The company is based in New York, NY. The company's methods and technologies allow users to Play The Web®, improve usability, and add safety measures. It was founded by Damon C. Torres, who has been the CEO since incorporation. | Directeur/Membre du Conseil | 14/02/2022 |
Viamet Pharmaceuticals, Inc.
 Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals, Inc. discovers and develops inhibitors of validated metalloenzymes. The firm's clinical portfolio includes novel agents to treat both chronic and life threatening fungal infections. It also leverage our metalloenzyme expertise in other therapeutic areas including oncology and orphan diseases. The company was founded by Thomas V. O’Halloran and Holden H. Thorp on August 18, 2005 and is headquartered in Durham, NC. | Directeur/Membre du Conseil | - |
Lurie Holdings, Inc.
 Lurie Holdings, Inc. Investment ManagersFinance Lurie Holdings Inc (Lurie Holdings) is a venture capital subsidiary of Ann & Robert H. Lurie Family Foundation founded in 1995. The firm is headquartered in Chicago, Illinois. | President | 24/04/2023 |
Anciens postes connus de Theodore J. Theophilos
| Sociétés | Poste | Fin |
|---|---|---|
Moore Wallace, Inc.
 Moore Wallace, Inc. Commercial Printing/FormsCommercial Services Moore Wallace, Inc. provides solutions in commercial printing, forms and labels, direct mail, financial printing, print fulfillment, business communication outsourcing, logistics, online services, digital photography, and content and database management | Conseiller Juridique Général | 01/02/2004 |
| R. R. DONNELLEY & SONS COMPANY | Corporate Officer/Principal | - |
Formation de Theodore J. Theophilos
| Northwestern University | Graduate Degree |
| The University of Chicago | Graduate Degree |
| The University of Chicago Law School | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Moore Wallace, Inc.
Moore Wallace, Inc. Commercial Printing/FormsCommercial Services Moore Wallace, Inc. provides solutions in commercial printing, forms and labels, direct mail, financial printing, print fulfillment, business communication outsourcing, logistics, online services, digital photography, and content and database management | Commercial Services |
R.R. Donnelley & Sons Co.
 R.R. Donnelley & Sons Co. Advertising/Marketing ServicesCommercial Services R.R. Donnelley & Sons Co. engages in the provision of multichannel communication solutions. It operates through the following segments: Commercial Print, Logistics, Statement Printing, Labels, Packaging, Supply Chain Management, Forms and Business Process Outsourcing. The Commercial Print segment provides various commercial printing products and offer a full range of branded materials including manuals, publications, brochures, business cards, flyers, post cards, posters and promotional items. The Packaging segment provide packaging solutions, ranging from rigid boxes to in-box print materials, for clients in consumer electronics, life sciences, cosmetics and consumer packaged goods industries. The Statement Printing creates critical business communications, including customer billings, financial statements, healthcare communications and insurance documents. The Labels segment produces custom labels for clients across multiple industries including warehouse and distribution, retail, pharmaceutical, manufacturing and consumer packaging. The Supply Chain Management segment provides workflow design to assembly, configuration, kitting and fulfillment for clients in consumer electronics, telecommunications, life sciences, cosmetics, education and industrial industries. The Forms segment produces a variety of forms including invoices, order forms and business forms that support both the private and public sectors for clients in financial, government, retail, healthcare and business services industries and The Business Process Outsourcing segment provides outsourcing services including creative services, research and analytics, financial management and other services for legal providers, insurance, telecommunications, utilities, retail and financial services companies. The company was founded by Richard Robert Donnelley in 1864 and is headquartered in Chicago, IL. | Commercial Services |
Innocrin Pharmaceuticals, Inc.
Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC. | Health Technology |
Robocast , Inc.
Robocast , Inc. Internet Software/ServicesTechnology Services Robocast, Inc. is a company that licenses its methods and technologies to major companies. The company is based in New York, NY. The company's methods and technologies allow users to Play The Web®, improve usability, and add safety measures. It was founded by Damon C. Torres, who has been the CEO since incorporation. | Technology Services |
Viamet Pharmaceuticals, Inc.
Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals, Inc. discovers and develops inhibitors of validated metalloenzymes. The firm's clinical portfolio includes novel agents to treat both chronic and life threatening fungal infections. It also leverage our metalloenzyme expertise in other therapeutic areas including oncology and orphan diseases. The company was founded by Thomas V. O’Halloran and Holden H. Thorp on August 18, 2005 and is headquartered in Durham, NC. | Health Technology |
Lurie Holdings, Inc.
Lurie Holdings, Inc. Investment ManagersFinance Lurie Holdings Inc (Lurie Holdings) is a venture capital subsidiary of Ann & Robert H. Lurie Family Foundation founded in 1995. The firm is headquartered in Chicago, Illinois. | Finance |
